Cargando…

Intravenous administration of anakinra in children with macrophage activation syndrome

BACKGROUND: Subcutaneous anakinra is an interleukin-1 inhibitor used to treat juvenile idiopathic arthritis. Recent reports suggest anakinra can be a valuable addition to the treatment of COVID-19 associated cytokine storm syndrome and the related multisystem inflammatory syndrome (MIS-C) in childre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phadke, Omkar, Rouster-Stevens, Kelly, Giannopoulos, Helen, Chandrakasan, Shanmuganathan, Prahalad, Sampath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240425/ https://www.ncbi.nlm.nih.gov/pubmed/34187503 http://dx.doi.org/10.1186/s12969-021-00585-3

Ejemplares similares

Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases
por: Villacis-Nunez, D. Sofia, et al.
Publicado: (2021)

2114 Severity of childhood-onset systemic lupus erythematosus: Impact of preceding and co-existing autoimmune cytopenias (protocol)
por: Akan, Ekemini, et al.
Publicado: (2018)

Clinical Determinants of Childhood Onset Systemic Lupus Erythematosus among Early and Peri-Adolescent Age Groups
por: Nelson, Meghan Corrigan, et al.
Publicado: (2022)

Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
por: Monteagudo, Luke Adam, et al.
Publicado: (2020)

Intravenous anakinra for cytokine storm syndromes
por: Jamilloux, Yvan, et al.
Publicado: (2020)

Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
por: Mehta, Puja, et al.
Publicado: (2020)

Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children
por: Alolayan, Abdulaziz, et al.
Publicado: (2023)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

86. Intravenous anakinra treatment in a rare case of macrophage activation syndrome presenting as fulminant liver failure
por: Ghuman, Abeer, et al.
Publicado: (2018)

Giant Coronary Aneurysms in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection
por: Villacis-Nunez, D. Sofia, et al.
Publicado: (2021)

Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children
por: Villacis-Nunez, D. Sofia, et al.
Publicado: (2022)

Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019
por: Wampler Muskardin, Theresa L.
Publicado: (2020)

Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra
por: Meneghel, Alessandra, et al.
Publicado: (2021)

Editorial: Dermatologic manifestations of primary immune deficiency disorders in children
por: Shamriz, Oded, et al.
Publicado: (2023)

Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
por: Angeles-Han, Sheila T., et al.
Publicado: (2015)

Discovery of tear biomarkers in children with chronic non-infectious anterior uveitis: a pilot study
por: Angeles-Han, Sheila T., et al.
Publicado: (2018)

Safety of intravenous anakinra in COVID-19 with evidence of hyperinflammation, a case series
por: Clark, Kristina E N, et al.
Publicado: (2020)

Use of Intravenous Anakinra for Management of Pediatric Cytokine Storm Syndromes at an Academic Medical Center
por: Yang, Lirong, et al.
Publicado: (2023)

Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing
por: Imbach, Kathleen J., et al.
Publicado: (2023)

Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
por: Kumar, Deepak, et al.
Publicado: (2022)

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever
por: Calligaris, Lorenzo, et al.
Publicado: (2007)

Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra
por: Kumar, Aswini, et al.
Publicado: (2016)

Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection–related epilepsy syndrome
por: Dilena, Robertino, et al.
Publicado: (2019)

Sevoflurane as bridge therapy for plasma exchange and Anakinra in febrile infection–related epilepsy syndrome
por: L’Erario, Manuela, et al.
Publicado: (2021)

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series
por: Ragamin, Aviël, et al.
Publicado: (2023)

Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Bhat, Chandrika S., et al.
Publicado: (2021)

4396 Immunoglobulin administration and hypogammaglobulinemia during pediatric acute leukemia therapy
por: Edington, Holly, et al.
Publicado: (2020)

Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)

Refractory Sweet Syndrome Treated with Anakinra
por: Shahid, Zainab, et al.
Publicado: (2019)

The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLH
por: Kavirayani, Akhila, et al.
Publicado: (2020)

Chronic Autoimmune Meningoencephalitis and Periodic Fever Syndrome Treated with Anakinra
por: Novroski, Alyssa-Rae, et al.
Publicado: (2017)

Familial autoimmunity in the childhood arthritis and rheumatology research alliance registry
por: Prahalad, Sampath, et al.
Publicado: (2016)

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations
por: Kaiser, Christina, et al.
Publicado: (2011)

Effect of anakinra on arthropathy in CINCA/NOMID syndrome
por: Miyamae, Takako, et al.
Publicado: (2010)

Schnitzler Syndrome: A Dramatic Response to Anakinra
por: Gouveia, Ana Isabel, et al.
Publicado: (2016)

Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)

Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
por: Bossi, Grazia, et al.
Publicado: (2022)

A Novel Therapy for a Rare Condition: Continuous Anakinra Infusion for a Patient With Macrophage Activation Syndrome
por: Gullickson, Mitch, et al.
Publicado: (2023)

Long‐term administration of intravenous inotropes in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2021)

Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates
por: Rouini, Mohammad-Reza, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_82rr7knmj1glp750mf85587uj7